Warning letters, 483s, Recalls, Import Alerts, Audit observations
Lorem ipsum is a dummy or placeholder text commonly used in graphic design, publishing, and
Natco Pharma (india) Kothur facility was inspected by USFDA (Investigators Pratik S. Upadhyay and Saleem
Lorem ipsum, placeholder or dummy text used in typesetting and graphic design for previewing layouts. It
Wriggling critters armed with enzymes can break down plastics that would otherwise take decades, or
Vamorolone is a synthetic corticosteroid approved by USFDA for the treatment of Duchenne Muscular Dystrophy
Centaur India formulation facility at Pune, Maharashtra, India was issued Warning letter by FDA citing
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
USFDA 483 to Intas cites lapses in investigation and review of failures and discrepancies in
USFDA Inspected IPCA (Ratlam, India) site in June 2023, Inspectors – Rajiv R Srivastava, Salim
